Abstract: The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.

Abstract: A system and methods for the treatment of amblyopia are described. The system includes a display system capable of delivering a second image to a second eye of a patient and a first image to a first eye of a patient. The system also includes a controller capable of delaying the delivery of the second image to the second eye of the patent. The controller is configured to receive the second image and the first image. The controller is also configured to identify a delay factor associated with the second image. The controller is also configured to provide the first image to the display system for viewing by the first eye of the patient. The controller is also configured such that after a delay determined by the delay factor, the controller provides the second image to the display system for viewing by the second eye of the patient.

Abstract: A system and methods for the treatment of amblyopia are described. The system includes a display system capable of in delivering a second image to a second eye of a patient and a first image to a first eye of a patient. The system also includes a controller in capable of delaying the delivery of the second image to the second eye of the patent. The controller is configured to receive the second image and the first image. The controller is also configured to identify a delay factor associated with the second image. The controller is also configured to provide the first image to the display system for viewing by the first eye of the patient. The controller is also configured such that after a delay determined by the delay factor, the controller provides the second image to the display system for viewing by the second eye of the patient.

Abstract: A system and methods for the treatment of amblyopia are described. The system includes a display system capable of in delivering a second image to a second eye of a patient and a first image to a first eye of a patient. The system also includes a controller in capable of delaying the delivery of the second image to the second eye of the patent. The controller is configured to receive the second image and the first image. The controller is also configured to identify a delay factor associated with the second image. The controller is also configured to provide the first image to the display system for viewing by the first eye of the patient. The controller is also configured such that after a delay determined by the delay factor, the controller provides the second image to the display system for viewing by the second eye of the patient.

Abstract: Methods and systems for maintaining user attention during a treatment are disclosed. The method comprises measuring at least one user parameter when presenting treatment content to the user via at least one display screen, determining whether the user is engaged with the presented treatment content based on the at least one measured user parameter, presenting an attention booster to the user upon determining the user is not engaged with the treatment content. The system comprises at least one display apparatus configured to present treatment content to the user and a processor configured to execute instructions stored on a memory to measure at least one user parameter when the treatment content is presented to the user, determine whether the user is engaged with the presented treatment content based on the at least one measured user parameter, and output to the display apparatus an attention booster to the user upon determining the user is not engaged with the presented treatment content.

Abstract: In various embodiments, a head-mounted apparatus having first and second display screens for, respectively, displaying visual content dichoptically to left and right eyes of a user is utilized to treat, improve, or prevent degradation of the user's vision.

Abstract: In various embodiments, methods of treating, improving, or preventing degradation of a user's vision incorporate the display of visual content dichoptically to the left and right eye of the user while the accommodative demand placed on the left eye and/or the right eye is altered.